Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The emergence of the theranostic sees drugs firms looking for partners in diagnostics - Update

This article was originally published in Clinica

Executive Summary

A new breed of product is emerging - nestled between diagnostics and therapeutics is the "theranostic", or maybe even the "therametric". Defined as a test that influences therapeutic decisions, it might identify candidates for drug therapy or could be used to provide feedback on how well a drug is working. Zosia Chustecka looks at developments in this nascent field.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel